EJ
Eric Joseph JP Morgan Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
15
Avg Return
Past Year
Past Year
12%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
64.7%
Neutral
29.4%
Negative
5.9%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Materials
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Materials
Chemicals
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Upgraded
| $11 |
136%
upside
| 1 | +11% |
0
%
| 17 Dec ‘25 23 days ago |
|
|
|
Overweight
Maintained
| $49 |
72%
upside
| 1 | -18% |
0
%
| 3 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $46 |
67%
upside
| 1 | +2% |
0
%
| 9 Oct ‘25 3 months ago |
|
|
|
Overweight
Maintained
| $64 |
14%
downside
| 2 | +58% |
0
%
| 3 Jun ‘25 7 months ago |
|
|
|
Neutral
Downgraded
| – | – | 1 | – |
–
| 20 May ‘25 7 months ago |
|
|
|
Overweight
Maintained
| $44 |
1,080%
upside
| 1 | -47% |
0
%
| 9 May ‘25 8 months ago |
|
|
|
Underweight
Maintained
| $7 |
4%
downside
| 1 | -9.2% |
0
%
| 9 May ‘25 8 months ago |
|
|
|
Overweight
Maintained
| $67 |
14%
downside
| 4 | +22% |
0
%
| 7 May ‘25 8 months ago |
|
|
|
Neutral
Initiated
| – | – | 1 | – |
–
| 25 Apr ‘25 8 months ago |
|
|
|
Neutral
Upgraded
| – | – | 1 | – |
–
| 24 Feb ‘25 10 months ago |
|
|
|
Neutral
Downgraded
| – | – | 1 | – |
–
| 10 Feb ‘25 11 months ago |
|
|
|
Overweight
Maintained
| $30 |
55%
upside
| 1 | -1.3% |
0
%
| 29 Jan ‘25 11 months ago |
|
|
|
Neutral
Upgraded
| – | – | 1 | +87% |
–
| 13 Jan ‘25 1 year ago |
|